Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami N Malek

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Oncotarget|April 14, 2011
Biomarkers in NHLSami N Malek
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
CRISPR/Cas9-Based Gene Dropout ScreensKai Wu, Sami N Malek
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
Gene Disruption Using CRISPR-Cas9 TechnologyNan Hu, Sami N Malek
Seminars in Oncology|April 5, 2016
Gene mutations in chronic lymphocytic leukemiaNisar A Amin, Sami N Malek
Leukemia Research|December 14, 2002
Commentary: topoisomerases as targets in acute leukemia: I, II, I plus II or none?Sami N Malek, Steven D Gore
Seminars in Oncology|August 27, 2003
Incorporating monoclonal antibodies in blood and marrow transplantationSami N Malek, Ian W Flinn
Cell Cycle (Georgetown, Tex.)|April 17, 2008
The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to MDM2 inhibitor-mediated apoptosisDale Bixby, Lisa Kujawski, Shaomeng Wang, et al.
Current Treatment Options in Oncology|August 29, 2003
MALT LymphomasSami N Malek, Amy J Hatfield, Ian W Flinn
Autophagy|April 28, 2022
Mutations in V-ATPase in follicular lymphoma activate autophagic flux creating a targetable dependencyFangyang Wang, Ying Yang, Daniel J Klionsky, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
Analysis of acquired genomic copy number aberrations and regions of loss of heterozygosity in acute myelogenous leukemia genomes using Affymetrix SNP 6.0 arrays and supporting software toolsPeter D Ouillette, Kerby A Shedden, Cheng Li, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Oncotarget|April 14, 2011
Biomarkers in NHLSami N Malek
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
CRISPR/Cas9-Based Gene Dropout ScreensKai Wu, Sami N Malek
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
Gene Disruption Using CRISPR-Cas9 TechnologyNan Hu, Sami N Malek
Seminars in Oncology|April 5, 2016
Gene mutations in chronic lymphocytic leukemiaNisar A Amin, Sami N Malek
Leukemia Research|December 14, 2002
Commentary: topoisomerases as targets in acute leukemia: I, II, I plus II or none?Sami N Malek, Steven D Gore
Seminars in Oncology|August 27, 2003
Incorporating monoclonal antibodies in blood and marrow transplantationSami N Malek, Ian W Flinn
Cell Cycle (Georgetown, Tex.)|April 17, 2008
The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to MDM2 inhibitor-mediated apoptosisDale Bixby, Lisa Kujawski, Shaomeng Wang, et al.
Current Treatment Options in Oncology|August 29, 2003
MALT LymphomasSami N Malek, Amy J Hatfield, Ian W Flinn
Autophagy|April 28, 2022
Mutations in V-ATPase in follicular lymphoma activate autophagic flux creating a targetable dependencyFangyang Wang, Ying Yang, Daniel J Klionsky, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
Analysis of acquired genomic copy number aberrations and regions of loss of heterozygosity in acute myelogenous leukemia genomes using Affymetrix SNP 6.0 arrays and supporting software toolsPeter D Ouillette, Kerby A Shedden, Cheng Li, et al.
Pageof 6